Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.

The researchers suggest that inflammation could be a key mechanism in the development of long COVID, potentially causing symptoms that emerge months after the acute phase of the disease resolves.

This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.

This study reported that a treatment regimen of oral rifampicin and clindamycin for 10 weeks effectively managed folliculitis decalvans, with most patients experiencing no recurrence after one or multiple courses.

This study found that oral isotretinoin achieved good to excellent clinical results in treating severe inflammatory acne, severe rosacea, and gram-negative folliculitis.

This review outlines the diagnosis and management of folliculitis decalvans, an inflammatory scalp disorder, and highlights Staphylococcus aureus and immune response deficiencies as key factors in its development.

This study found that severe folliculitis decalvans was associated with its onset before age 25 and the presence of pustules, while tetracyclines and clindamycin plus rifampicin were effective treatments.

This review describes various types of folliculitis based on their causes, clinical manifestations, and treatments, but reports no new clinical results.

This article discusses the causes, development, treatment, and prevention strategies for pseudofolliculitis barbae and folliculitis keloidalis nuchae, but reports no new clinical results.

This study found that most patients with folliculitis decalvans showed improvement and remission with oral antibiotics, although some experienced relapses and required prolonged treatment.

This study examined the therapeutic response to folliculitis decalvans treatments among 60 patients and found that earlier disease onset was linked to more severe cases, while a combination of rifampicin, clindamycin, tetracyclines, and intralesional steroids was most effective in controlling symptoms.

This study reported that a 10-week course of clindamycin and rifampicin was commonly used for treating folliculitis decalvans but the evidence on its efficacy remains inconclusive due to the low quality of available studies.

This report on identical female twins with folliculitis decalvans suggests a possible genetic component to the disease, marking the first such case in twins.

This study found that among patients with folliculitis decalvans, treatment with isotretinoin achieved the highest rate of stable remission compared to antibiotic regimens like clindamycin and rifampicin.

This case series reports 13 patients with folliculitis decalvans treated with antimicrobial therapy, highlighting the variability in response outcomes for this challenging condition.

This case report details a 37-year-old man who developed eosinophilic pustular dermatosis after previously resolving herpes zoster, with successful treatment using itraconazole and cycloproxolamine.

This case study describes a pregnant woman who developed a pruritic rash with follicular lesions containing yeast-like organisms, resistant to conventional acne treatments.

This report describes a case where a recalcitrant folliculitis decalvans was successfully treated with a long-pulsed Nd:YAG laser.

This case report describes a patient with folliculitis decalvans who successfully responded to photodynamic therapy.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Adalimumab improved folliculitis decalvans in most patients.

This case report describes an adult patient with tinea capitis due to Microsporum canis who experienced complete hair regrowth following treatment with fluconazole and ketoconazole shampoo.

In this retrospective study, oral isotretinoin monotherapy effectively achieved remission in 82% of patients with folliculitis decalvans, with those receiving ≥0.4 mg/kg/day for ≥3 months experiencing better outcomes and less frequent relapse.

This article reviews prominent variants of scalp hair folliculitis and their differential diagnosis, but reports no new clinical findings.

Chronic scalp inflammation can turn into cancer, so regular check-ups are important.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

In this report, a 26-year-old man with folliculitis decalvans unresponsive to standard treatments experienced significant disease clearance after 25 months of systemic photodynamic therapy, marking the first documented use of this therapy for this condition.

This case report describes a man with Touraine-Solente-Golé syndrome who achieved substantial improvement of tufted hair folliculitis after treatment with amoxicillin, clavulanic acid, and topical nadifloxacin.

Postoperative folliculitis after hair transplants is a minor issue that doesn't relate to patient details or how much hair is transplanted.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.